Pasithea Therapeutics Corp. (KTTA:NASDAQ) rocketted at $0.5, representing a gain of 25%. On Mon, Jun 05, 2023, KTTA:NASDAQ touched a New 2-Week High of $0.5. The stock appeared on our News Catalysts scanner on Mon, Jun 05, 2023 at 10:49 AM in the 'ACQUISITION' category. From Mon, May 22, 2023, the stock recorded 66.67% Up Days and 40.00% Green Days
The stock spiked on Mon, Jun 05, 2023 at $0.64 with a volume of 1M+.
About Pasithea Therapeutics Corp. (KTTA:NASDAQ)
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the research and discovery of new and effective treatments for psychiatric and neurological disorders.
Top 10 Gainers:
- Forza X1 Inc. (FRZA:NASDAQ), 133.6%
- Sevcon, Inc. (SEV:NASDAQ), 76.5%
- Chijet Motor Company Inc. (CJET:NASDAQ), 54.05%
- CIRCOR International, Inc. (CIR:NYSE), 51.06%
- Ucommune International Ltd (UK:NASDAQ), 50.29%
- Mangoceuticals Inc. (MGRX:NASDAQ), 29.46%
- Timber Pharmaceuticals Inc. (TMBR:NYSEMKT), 26.17%
- Pasithea Therapeutics Corp. (KTTA:NASDAQ), 25%
- WeWork Inc. Class A (WE:NYSE), 24.38%
- Scilex Holding Company Com (SCLX:NASDAQ), 22.78%